Author: admin
Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer’s as a potential first indication. Longevity biotech Retro Biosciences has achieved its goal of becoming a clinical-stage company in 2025, after dosing the first participant in a clinical trial of its autophagy-focused drug candidate. The San Francisco–based company enters the clinic following reports earlier this year that it was preparing to raise as much as $1 billion to support its next phase of growth, having already raised a $180 million seed round funded exclusively by OpenAI boss Sam Altman. Retro’s clinical drug candidate, RTR242, is a small-molecule…
Insilico Medicine IPO signals that AI‑native drug discovery is moving from promise to public markets with a central longevity narrative. Insilico Medicine (3696.HK) has successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public on the Main Board under HKEX Chapter 8.05 listing rules. This initial public offering (IPO) raised a total of HK$2.277b ($293m), marking the largest biotech IPO in Hong Kong this year by funds raised [1]. Alex Zhavoronkov, PhD, Founder, CEO & CBO of Insilico Medicine. “With this massively oversubscribed listing we set several world firsts, further confirming Insilico’s…
Walk into a standard grocery store, and you see rows of white and brown cartons filled with chicken eggs. But lately, sitting quietly next to them—or perhaps found in the gourmet section or your local farmer’s market—are tiny, speckled gems: quail eggs. Once considered a delicacy reserved for sushi bars and high-end French cuisine, quail eggs are gaining traction as a daily superfood. Health enthusiasts claim they are packed with more vitamins, are safer for allergy sufferers, and taste creamier than the standard chicken egg. But are these claims true, or is it just hype wrapped in a cute, spotted…
Scientists made advances in various aspects of molecular biology.Image credit:© iStock.com, D3DamonFrom the molecules that drive fundamental cellular processes to the signals that influence disease, the field of molecular biology continues to reshape how scientists understand life. Read the top molecular biology stories of this year that delve into how plastic additives influence biology, how venoms affect blood vessels, and more. Plastic is everywhere in modern life, from packaging and clothing to electronics and medicine, because it is cheap, durable, and versatile. However, some additives in plastics, such as benzyl butyl phthalate (BBP), which makes plastic products flexible and durable,…
Using real-time brainwave data, clinics claim to help focus, mood and memory – can retraining neural circuits slow cognitive decline? Neurofeedback sits in that intriguing borderland between hard neuroscience and soft promise. It is non-invasive brain training built on real-time monitoring of neuronal activity, typically via electroencephalography (EEG) and more rarely through functional imaging. The premise is disarmingly simple: show the brain what it is doing as it does it; let it practice doing something else. Through electrodes placed on the scalp, EEG detects patterns of electrical activity generated by synchronized neuronal firing; software then translates those patterns into immediate…
Inspired by biomimicry, this postdoc investigates how material structure governs energy conversion efficiency.Image credit:University of Exeter, ©iStock.com, PetmalQ | Write a brief introduction to yourself including the lab you work in and your research background. My name is Anurag Roy. I am a research fellow at the University of Exeter in the Renewable Engineering department. As a material chemist, I focus on energy harvesting materials, studying their structure-property-performance relationships. I completed my PhD in 2019 at CSIR-CGCRI and Jadavpur University, before continuing my research here.Q | How did you first get interested in science and/or your field of research? I’ve…
New research suggests that DNA inherited from prehistoric hunter-gatherers could quietly boost the chances of living to 100. We like to believe that living longer is all about discipline: eat well, move more, stress less. And while that still matters, a new study published in GeroScience suggests that some people may have a small but meaningful advantage they did nothing to earn, except be born into the right genetic family tree [1]. According to the research, ancient hunter-gatherer genes passed down over thousands of years could be helping modern humans live longer. Literally. The study focuses on Italy, a country…
As skincare heads into 2026, experts say skin longevity will define where innovation, investment and consumer trust converge. If 2025 proved anything, it’s that skincare has firmly moved beyond trends driven by hype alone. The category has matured into one of the most innovation-heavy corners of consumer health, blending beauty, biotech and preventative care. From more innovative formulations to gentler delivery systems, the focus has shifted toward results that last. As brands and investors look ahead to 2026, one theme cuts across expert predictions: skin longevity [1]. Rather than chasing fast fixes, consumers are playing the long game, prioritizing prevention,…
Singapore-based healthcare firm expands into stem cell therapies and longevity as demand for proactive aging solutions grows across Asia. Singapore-based health technology company EUDA Health Holdings Limited has taken a major step in its longevity strategy with the launch of a comprehensive stem cell therapy platform and the opening of its first longevity clinic in Shenzhen, China. The move marks a shift from planning to execution as the company positions itself at the intersection of regenerative medicine, preventive healthcare, and aging innovation. For EUDA, this is not simply about opening a new clinic. It is about building an end-to-end system…
Epigenetic rejuvenation gears up for the clinic, the power of plasma exchange and the final interview with a longevity biotech pioneer. Continuing our review of some of our most interesting interviews from the past year, here we focus on some of the cutting-edge work being conducted in the longevity field. Spanning progress in epigenetic rejuvenation and therapeutic plasma exchange, we also explored the sci-fi-sounding world of synthetic replacement. But first, let’s reflect on what would turn out to be the final interview with the CEO of Unity Biotechnology, which closed its doors a matter of days later, following a clinical…